1 Min Read
* SAYS STARTS CLINICAL STUDIES WITH NEW COMPOUND PM14 IN PATIENTS WITH SOLID TUMORS Source text for Eikon:
Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.